|
gptkbp:addressed
|
healthcare policies
|
|
gptkbp:affects
|
millions of women worldwide
|
|
gptkbp:can_be_asymptomatic_in
|
early stages
|
|
gptkbp:can_lead_to
|
metastasis
|
|
gptkbp:cause
|
cancer deaths in women
|
|
gptkbp:diagnosis
|
Pap smear
|
|
gptkbp:has_a_focus_on
|
research studies
screening programs
screening guidelines
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
cervical cancer
|
|
gptkbp:is_a_public_health_issue_in
|
developing countries
|
|
gptkbp:is_a_subject_of
|
gptkb:medical_research
gptkb:guidelines
patient education
advocacy efforts
|
|
gptkbp:is_associated_with
|
healthcare access issues
|
|
gptkbp:is_common_in
|
women over 30
|
|
gptkbp:is_influenced_by
|
lifestyle choices
socioeconomic factors
cultural beliefs
immune system status
|
|
gptkbp:is_linked_to
|
genetic factors
smoking
multiple sexual partners
early sexual activity
long-term use of oral contraceptives
|
|
gptkbp:is_monitored_by
|
follow-up screenings
|
|
gptkbp:is_part_of
|
women's health initiatives
|
|
gptkbp:is_preventable_through
|
regular screenings
|
|
gptkbp:issues
|
gynecologists
women's health advocates
|
|
gptkbp:prevention
|
gptkb:HPV_vaccine
|
|
gptkbp:scientific_classification
|
gptkb:Oncology
|
|
gptkbp:screenings
|
gptkb:HPV_testing
|
|
gptkbp:treatment
|
gptkb:surgery
radiation therapy
chemotherapy
targeted therapy
|
|
gptkbp:type_of
|
gptkb:Oncology
|
|
gptkbp:bfsParent
|
gptkb:National_Institutes_of_Health
|
|
gptkbp:bfsLayer
|
3
|